524 related articles for article (PubMed ID: 29277549)
1. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
2. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
3. FOXP1 inhibits high glucose-induced ECM accumulation and oxidative stress in mesangial cells.
Xiang H; Xue W; Wu X; Zheng J; Ding C; Li Y; Dou M
Chem Biol Interact; 2019 Nov; 313():108818. PubMed ID: 31494106
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
Pessôa BS; Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):56-66. PubMed ID: 21987533
[TBL] [Abstract][Full Text] [Related]
5. XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy.
Wang Y; He Z; Yang Q; Zhou G
FEBS Open Bio; 2019 Jul; 9(7):1249-1258. PubMed ID: 31077568
[TBL] [Abstract][Full Text] [Related]
6. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
Graham S; Gorin Y; Abboud HE; Ding M; Lee DY; Shi H; Ding Y; Ma R
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C304-15. PubMed ID: 21525431
[TBL] [Abstract][Full Text] [Related]
7. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
9. AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.
Qin J; Peng Z; Yuan Q; Li Q; Peng Y; Wen R; Hu Z; Liu J; Xia X; Deng H; Xiong X; Hu J; Tao L
Sci Rep; 2019 Mar; 9(1):4407. PubMed ID: 30867431
[TBL] [Abstract][Full Text] [Related]
10. Apocynin inhibited NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy.
Xin R; Sun X; Wang Z; Yuan W; Jiang W; Wang L; Xiang Y; Zhang H; Li X; Hou Y; Sun W; Du P
Biomed Pharmacother; 2018 Oct; 106():1325-1331. PubMed ID: 30119203
[TBL] [Abstract][Full Text] [Related]
11. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
[TBL] [Abstract][Full Text] [Related]
12. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.
Zhang L; Pang S; Deng B; Qian L; Chen J; Zou J; Zheng J; Yang L; Zhang C; Chen X; Liu Z; Le Y
Int J Biochem Cell Biol; 2012 Apr; 44(4):629-38. PubMed ID: 22245600
[TBL] [Abstract][Full Text] [Related]
13. Suppression of XBP1S mediates high glucose-induced oxidative stress and extracellular matrix synthesis in renal mesangial cell and kidney of diabetic rats.
Shao D; Liu J; Ni J; Wang Z; Shen Y; Zhou L; Huang Y; Wang J; Xue H; Zhang W; Lu L
PLoS One; 2013; 8(2):e56124. PubMed ID: 23457509
[TBL] [Abstract][Full Text] [Related]
14. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
15. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
Lee WJ; Liu SH; Chiang CK; Lin SY; Liang KW; Chen CH; Tien HR; Chen PH; Wu JP; Tsai YC; Lai DW; Chang YC; Sheu WH; Sheu ML
Antioxid Redox Signal; 2016 Feb; 24(4):217-231. PubMed ID: 26415004
[TBL] [Abstract][Full Text] [Related]
16. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
Zhu X; Shi J; Li H
Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
[TBL] [Abstract][Full Text] [Related]
17. Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway.
Ying C; Chen L; Wang S; Mao Y; Ling H; Li W; Zhou X
Biomed Pharmacother; 2017 Jun; 90():796-805. PubMed ID: 28431381
[TBL] [Abstract][Full Text] [Related]
18. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
19. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
Wang S; Zhao X; Yang S; Chen B; Shi J
Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs.
Xie X; Chen Q; Tao J
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29621130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
